rss

Gut
Supplementary Material

Supplementary material related to the following articles is available online:

  • Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens

    • J G Fox,
    • Y Feng,
    • E J Theve,
    • A R Raczynski,
    • J L A Fiala,
    • A L Doernte,
    • M Williams,
    • J L McFaline,
    • J M Essigmann,
    • D B Schauer,
    • S R Tannenbaum,
    • P C Dedon,
    • S A Weinman,
    • S M Lemon,
    • R C Fry,
    • and A B Rogers
    2010 59:88-97

  • Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer

    • G Kijanka,
    • S Hector,
    • E W Kay,
    • F Murray,
    • R Cummins,
    • D Murphy,
    • B D MacCraith,
    • J H M Prehn,
    • and D Kenny
    2010 59:69-78

  • Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study

    • J Steevens,
    • L J Schouten,
    • R A Goldbohm,
    • and P A van den Brandt
    2010 59:39-48

  • Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial

    • A Straumann,
    • S Conus,
    • P Grzonka,
    • H Kita,
    • G Kephart,
    • C Bussmann,
    • C Beglinger,
    • D A Smith,
    • J Patel,
    • M Byrne,
    • and H-U Simon
    2010 59:21-30

  • Involvement of JNK pathway in the promotion of the early stage of colorectal carcinogenesis under high-fat dietary conditions

    • H Endo,
    • K Hosono,
    • T Fujisawa,
    • H Takahashi,
    • M Sugiyama,
    • K Yoneda,
    • Y Nozaki,
    • K Fujita,
    • M Yoneda,
    • M Inamori,
    • K Wada,
    • H Nakagama,
    • and A Nakajima
    2009 58:1637-1643

  • Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

    • I Arijs,
    • K Li,
    • G Toedter,
    • R Quintens,
    • L Van Lommel,
    • K Van Steen,
    • P Leemans,
    • G De Hertogh,
    • K Lemaire,
    • M Ferrante,
    • F Schnitzler,
    • L Thorrez,
    • K Ma,
    • X-Y R Song,
    • C Marano,
    • G Van Assche,
    • S Vermeire,
    • K Geboes,
    • F Schuit,
    • F Baribaud,
    • and P Rutgeerts
    2009 58:1612-1619

  • Gliadin-primed CD4+CD45RBlowCD25– T cells drive gluten-dependent small intestinal damage after adoptive transfer into lymphopenic mice

    • T L Freitag,
    • S Rietdijk,
    • Y Junker,
    • Y Popov,
    • A K Bhan,
    • C P Kelly,
    • C Terhorst,
    • and D Schuppan
    2009 58:1597-1605

  • Intracapillary leucocyte accumulation as a novel antihaemorrhagic mechanism in acute pancreatitis in mice

    • E Ryschich,
    • V Kerkadze,
    • O Deduchovas,
    • O Salnikova,
    • A Parseliunas,
    • A Märten,
    • W Hartwig,
    • M Sperandio,
    • and J Schmidt
    2009 58:1508-1516

  • Modelling dysplasia detection in ulcerative colitis: clinical implications of surveillance intensity

    • D Awais,
    • C A Siegel,
    • and P D R Higgins
    2009 58:1498-1503

  • Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells

    • I D Iliev,
    • I Spadoni,
    • E Mileti,
    • G Matteoli,
    • A Sonzogni,
    • G M Sampietro,
    • D Foschi,
    • F Caprioli,
    • G Viale,
    • and M Rescigno
    2009 58:1481-1489

  • Critical role of TRPC6 channels in G2 phase transition and the development of human oesophageal cancer

    • Y Shi,
    • X Ding,
    • Z-H He,
    • K-C Zhou,
    • Q Wang,
    • and Y-Z Wang
    2009 58:1443-1450

  • Obesity and Barrett’s oesophagus: more than just reflux

    • Julian A Abrams
    2009 58:1437-1438

  • Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men

    • Y Chang,
    • S Ryu,
    • E Sung,
    • H-Y Woo,
    • S-I Cho,
    • S-H Yoo,
    • H-Y Ahn,
    • and N-K Choi
    2009 58:1419-1425

  • HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA

    • P Fritsche,
    • B Seidler,
    • S Schüler,
    • A Schnieke,
    • M Göttlicher,
    • R M Schmid,
    • D Saur,
    • and G Schneider
    2009 58:1399-1409

  • CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models

    • W Schneiderhan,
    • M Scheler,
    • K-H Holzmann,
    • M Marx,
    • J E Gschwend,
    • M Bucholz,
    • T M Gress,
    • T Seufferlein,
    • G Adler,
    • and F Oswald
    2009 58:1391-1398

  • Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening

    • E K O Ng,
    • W W S Chong,
    • H Jin,
    • E K Y Lam,
    • V Y Shin,
    • J Yu,
    • T C W Poon,
    • S S M Ng,
    • and J J Y Sung
    2009 58:1375-1381

  • Anti-CTLA-4 treatment induces IL-10-producing ICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis

    • C Coquerelle,
    • G Oldenhove,
    • V Acolty,
    • J Denoeud,
    • G Vansanten,
    • J-M Verdebout,
    • A Mellor,
    • J A Bluestone,
    • and M Moser
    2009 58:1363-1373

  • Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn’s disease: a randomised, double-blind, placebo-controlled, phase 2 study

    • J F Valentine,
    • R N Fedorak,
    • B Feagan,
    • P Fredlund,
    • R Schmitt,
    • P Ni,
    • and T J Humphries
    2009 58:1354-1362

  • High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease

    • K Kantartzis,
    • C Thamer,
    • A Peter,
    • J Machann,
    • F Schick,
    • C Schraml,
    • A Königsrainer,
    • I Königsrainer,
    • S Kröber,
    • A Niess,
    • A Fritsche,
    • H-U Häring,
    • and N Stefan
    2009 58:1281-1288

  • Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2

    • S Modica,
    • A Morgano,
    • L Salvatore,
    • M Petruzzelli,
    • M-T Vanier,
    • R Valanzano,
    • D L Esposito,
    • G Palasciano,
    • I Duluc,
    • J-N Freund,
    • R Mariani-Costantini,
    • and A Moschetta
    2009 58:1250-1259

  • MHC Class II alleles in ulcerative colitis-associated colorectal cancer

    • M M Garrity-Park,
    • E V Loftus Jr,
    • W J Sandborn,
    • S C Bryant,
    • and T C Smyrk
    2009 58:1226-1233

  • The role of the novel Th17 cytokine IL-26 in intestinal inflammation

    • J Dambacher,
    • F Beigel,
    • K Zitzmann,
    • E N De Toni,
    • B Göke,
    • H M Diepolder,
    • C J Auernhammer,
    • and S Brand
    2009 58:1207-1217

  • A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease

    • C Keywood,
    • M Wakefield,
    • and J Tack
    2009 58:1192-1199

  • Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn’s disease

    • A M Muise,
    • T D Walters,
    • W K Glowacka,
    • A M Griffiths,
    • B-Y Ngan,
    • H Lan,
    • W Xu,
    • M S Silverberg,
    • and D Rotin
    2009 58:1121-1127

  • A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora

    • R J Rigby,
    • M R Hunt,
    • B P Scull,
    • J G Simmons,
    • K E Speck,
    • M A Helmrath,
    • and P K Lund
    2009 58:1104-1112

  • Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

    • P D Cani,
    • S Possemiers,
    • T Van de Wiele,
    • Y Guiot,
    • A Everard,
    • O Rottier,
    • L Geurts,
    • D Naslain,
    • A Neyrinck,
    • D M Lambert,
    • G G Muccioli,
    • and N M Delzenne
    2009 58:1091-1103

  • Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-{kappa}B signalling

    • G Trynka,
    • A Zhernakova,
    • J Romanos,
    • L Franke,
    • K A Hunt,
    • G Turner,
    • M Bruinenberg,
    • G A Heap,
    • M Platteel,
    • A W Ryan,
    • C de Kovel,
    • G K T Holmes,
    • P D Howdle,
    • J R F Walters,
    • D S Sanders,
    • C J J Mulder,
    • M L Mearin,
    • W H M Verbeek,
    • V Trimble,
    • F M Stevens,
    • D Kelleher,
    • D Barisani,
    • M T Bardella,
    • R McManus,
    • D A van Heel,
    • and C Wijmenga
    2009 58:1078-1083

  • Novel ways to sensitise gastrointestinal cancer to apoptosis

    • H Schulze-Bergkamen,
    • A Weinmann,
    • M Moehler,
    • J Siebler,
    • and P R Galle
    2009 58:1010-1024

  • Sulforaphane targets pancreatic tumour-initiating cells by NF-{kappa}B-induced antiapoptotic signalling

    • G Kallifatidis,
    • V Rausch,
    • B Baumann,
    • A Apel,
    • B M Beckermann,
    • A Groth,
    • J Mattern,
    • Z Li,
    • A Kolb,
    • G Moldenhauer,
    • P Altevogt,
    • T Wirth,
    • J Werner,
    • P Schemmer,
    • M W Büchler,
    • A V Salnikov,
    • and I Herr
    2009 58:949-963

  • Adalimumab for the treatment of fistulas in patients with Crohn’s disease

    • J-F Colombel,
    • D A Schwartz,
    • W J Sandborn,
    • M A Kamm,
    • G D’Haens,
    • P Rutgeerts,
    • R Enns,
    • R Panaccione,
    • S Schreiber,
    • J Li,
    • J D Kent,
    • K G Lomax,
    • and P F Pollack
    2009 58:940-948

  • Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis

    • E Gonzalez-Rey,
    • P Anderson,
    • M A González,
    • L Rico,
    • D Büscher,
    • and M Delgado
    2009 58:929-939

  • Reduced mucin sulfonation and impaired intestinal barrier function in the hyposulfataemic NaS1 null mouse

    • P A Dawson,
    • S Huxley,
    • B Gardiner,
    • T Tran,
    • J L McAuley,
    • S Grimmond,
    • M A McGuckin,
    • and D Markovich
    2009 58:910-919

  • The G191R variant in the PRSS2 gene does not play a role in protection against tropical calcific pancreatitis

    • S Mahurkar,
    • S Bhaskar,
    • D N Reddy,
    • G V Rao,
    • S P Singh,
    • V Thomas,
    • and G R Chandak
    2009 58:881-882

  • Antibiotic prophylaxis in gastrointestinal endoscopy

    • M C Allison,
    • J A T Sandoe,
    • R Tighe,
    • I A Simpson,
    • R J Hall,
    • T S J Elliott,
    • and prepared on behalf of the Endoscopy Committee of the British Society of Gastroenterology
    2009 58:869-880

  • Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis

    • E A M Festen,
    • P Goyette,
    • R Scott,
    • V Annese,
    • A Zhernakova,
    • J Lian,
    • C Lefèbvre,
    • S R Brant,
    • J H Cho,
    • M S Silverberg,
    • K D Taylor,
    • D J de Jong,
    • P C Stokkers,
    • D Mcgovern,
    • O Palmieri,
    • J-P Achkar,
    • R J Xavier,
    • M J Daly,
    • R H Duerr,
    • C Wijmenga,
    • R K Weersma,
    • and J D Rioux
    2009 58:799-804

  • Toll-like receptor 2 is critical for induction of Reg3β expression and intestinal clearance of Yersinia pseudotuberculosis

    • R Dessein,
    • M Gironella,
    • C Vignal,
    • L Peyrin-Biroulet,
    • H Sokol,
    • T Secher,
    • S Lacas-Gervais,
    • J-J Gratadoux,
    • F Lafont,
    • J-C Dagorn,
    • B Ryffel,
    • S Akira,
    • P Langella,
    • G Nùñez,
    • J-C Sirard,
    • J Iovanna,
    • M Simonet,
    • and M Chamaillard
    2009 58:771-776

  • A shadow of doubt

    • P J Allan,
    • S Appleton,
    • and A S McIntyre
    2009 58:617

  • Narrow-band imaging for improving colorectal adenoma detection: appropriate system function settings are required

    • T Uraoka,
    • Y Sano,
    • Y Saito,
    • H Saito,
    • T Matsuda,
    • and K Yamamoto
    2009 58:604-605

  • Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside?

    • P Sancho-Bru,
    • M Najimi,
    • M Caruso,
    • K Pauwelyn,
    • T Cantz,
    • S Forbes,
    • T Roskams,
    • M Ott,
    • U Gehling,
    • E Sokal,
    • C M Verfaillie,
    • and M Muraca
    2009 58:594-603

  • Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo

    • H Aurich,
    • M Sgodda,
    • P Kaltwaßer,
    • M Vetter,
    • A Weise,
    • T Liehr,
    • M Brulport,
    • J G Hengstler,
    • M M Dollinger,
    • W E Fleig,
    • and B Christ
    2009 58:570-581

  • Minigene analysis of intronic variants in common SPINK1 haplotypes associated with chronic pancreatitis

    • É Kereszturi,
    • O Király,
    • and M Sahin-Tóth
    2009 58:545-549

  • Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy

    • P H Dixon,
    • S W C van Mil,
    • J Chambers,
    • S Strautnieks,
    • R J Thompson,
    • F Lammert,
    • R Kubitz,
    • V Keitel,
    • A Glantz,
    • L-Å Mattsson,
    • H-U Marschall,
    • M Molokhia,
    • G E Moore,
    • K J Linton,
    • and C Williamson
    2009 58:537-544

  • KITENIN recruits Dishevelled/PKC{delta} to form a functional complex and controls the migration and invasiveness of colorectal cancer cells

    • D H Kho,
    • J A Bae,
    • J H Lee,
    • H J Cho,
    • S H Cho,
    • J H Lee,
    • Y-W Seo,
    • K Y Ahn,
    • I J Chung,
    • and K K Kim
    2009 58:509-519

  • Functional characterisation of decoy receptor 3 in Crohn’s disease

    • B Funke,
    • F Autschbach,
    • S Kim,
    • F Lasitschka,
    • U Strauch,
    • G Rogler,
    • G Gdynia,
    • L Li,
    • N Gretz,
    • S Macher-Goeppinger,
    • B Sido,
    • P Schirmacher,
    • S C Meuer,
    • and W Roth
    2009 58:483-491

  • Balancing the risks and benefits of prolonged use of infliximab

    • Jürgen Schölmerich
    2009 58:477-478

  • Recent advances in coeliac disease genetics

    • Karen A Hunt,
    • and David A van Heel
    2009 58:473-476

  • Immunosuppression for liver transplantation

    • E K Geissler,
    • and H J Schlitt
    2009 58:452-463

  • Mechanisms regulating cytochrome c release in pancreatic mitochondria

    • I V Odinokova,
    • K-F Sung,
    • O A Mareninova,
    • K Hermann,
    • Y Evtodienko,
    • A Andreyev,
    • I Gukovsky,
    • and A S Gukovskaya
    2009 58:431-442

  • Imaging after medically managed severe acute cholecystitis

    • T J Walton,
    • R Dhingsa,
    • P V Kaye,
    • and D N Lobo
    2009 58:421

  • Early preservation of effector functions followed by eventual T cell memory depletion: a model for the delayed onset of the effect of thiopurines

    • S Ben-Horin,
    • I Goldstein,
    • E Fudim,
    • O Picard,
    • Z Yerushalmi,
    • I Barshack,
    • I Bank,
    • Y Goldschmid,
    • S Bar Meir,
    • L Mayer,
    • and Y Chowers
    2009 58:396-403

  • Role of alkaline phosphatase in colitis in man and rats

    • A Tuin,
    • K Poelstra,
    • A de Jager-Krikken,
    • L Bok,
    • W Raaben,
    • M P Velders,
    • and G Dijkstra
    2009 58:379-387

  • Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis

    • A C Ford,
    • N J Talley,
    • P S Schoenfeld,
    • E M M Quigley,
    • and P Moayyedi
    2009 58:367-378

  • Water-soluble CO-releasing molecules reduce the development of postoperative ileus via modulation of MAPK/HO-1 signalling and reduction of oxidative stress

    • O De Backer,
    • E Elinck,
    • B Blanckaert,
    • L Leybaert,
    • R Motterlini,
    • and R A Lefebvre
    2009 58:347-356

  • Understanding the delayed onset of action of azathioprine in IBD: are we there yet?

    • Imke Atreya,
    • and Markus F Neurath
    2009 58:325-326

  • Increased ergothioneine tissue concentrations in carriers of the Crohn’s disease risk-associated 503F variant of the organic cation transporter OCTN1

    • D Taubert,
    • N Jung,
    • T Goeser,
    • and E Schömig
    2009 58:312-314

  • Vascular endothelial growth factor and angiopoietin-2 play a major role in the pathogenesis of vascular leakage in cirrhotic rats

    • P Melgar-Lesmes,
    • S Tugues,
    • J Ros,
    • G Fernández-Varo,
    • M Morales-Ruiz,
    • J Rodés,
    • and W Jiménez
    2009 58:285-292

  • Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells

    • H M Kocher,
    • J Sandle,
    • T A Mirza,
    • N F Li,
    • and I R Hart
    2009 58:271-284

  • Positive association of genetic variants in the upstream region of NKX2-3 with Crohn’s disease in Japanese patients

    • K Yamazaki,
    • A Takahashi,
    • M Takazoe,
    • M Kubo,
    • Y Onouchi,
    • A Fujino,
    • N Kamatani,
    • Y Nakamura,
    • and A Hata
    2009 58:228-232

  • CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells

    • A M Westendorf,
    • D Fleissner,
    • L Groebe,
    • S Jung,
    • A D Gruber,
    • W Hansen,
    • and J Buer
    2009 58:211-219

  • Does antidepressant medication in patients with hepatitis C undergoing interferon {alpha} treatment reduce therapeutic efficacy?

    • G Robaeys,
    • M C Wichers,
    • J De Bie,
    • G H Koek,
    • F Buntinx,
    • and J Van Os
    2009 58:145

  • Costs and cost-effectiveness of different follow-up schedules for detection of occupational hepatitis C virus infection

    • S Deuffic-Burban,
    • D Abiteboul,
    • F Lot,
    • M Branger,
    • E Bouvet,
    • and Y Yazdanpanah
    2009 58:105-110

  • Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression

    • B Carvalho,
    • C Postma,
    • S Mongera,
    • E Hopmans,
    • S Diskin,
    • M A van de Wiel,
    • W van Criekinge,
    • O Thas,
    • A Matthäi,
    • M A Cuesta,
    • J S Terhaar sive Droste,
    • M Craanen,
    • E Schröck,
    • B Ylstra,
    • and G A Meijer
    2009 58:79-89

  • Regulation of intestinal barrier function by signal transducer and activator of transcription 5b

    • X Han,
    • X Ren,
    • I Jurickova,
    • K Groschwitz,
    • B A Pasternak,
    • H Xu,
    • T A Wilson,
    • S P Hogan,
    • and L A Denson
    2009 58:49-58

  • JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction

    • M Selgrad,
    • R De Giorgio,
    • L Fini,
    • R F Cogliandro,
    • S Williams,
    • V Stanghellini,
    • G Barbara,
    • M Tonini,
    • R Corinaldesi,
    • R M Genta,
    • R Domiati-Saad,
    • R Meyer,
    • A Goel,
    • C R Boland,
    • and L Ricciardiello
    2009 58:25-32

  • DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett’s adenocarcinoma

    • D F Peng,
    • M Razvi,
    • H Chen,
    • K Washington,
    • A Roessner,
    • R Schneider-Stock,
    • and W El-Rifai
    2009 58:5-15

  • Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation

    • F Caprioli,
    • C Stolfi,
    • R Caruso,
    • D Fina,
    • G Sica,
    • L Biancone,
    • F Pallone,
    • and G Monteleone
    2008 57:1674-1680

  • CO2 chemosensing in rat oesophagus

    • Y Akiba,
    • M Mizumori,
    • M Kuo,
    • M Ham,
    • P H Guth,
    • E Engel,
    • and J D Kaunitz
    2008 57:1654-1664

  • Authors’ reply

    • S Kugathasan,
    • L J Saubermann,
    • L Smith,
    • D Kou,
    • J Itoh,
    • D G Binion,
    • A D Levine,
    • R S Blumberg,
    • and C Fiocchi
    2008 57:1629

  • Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition

    • T Fujisawa,
    • H Endo,
    • A Tomimoto,
    • M Sugiyama,
    • H Takahashi,
    • S Saito,
    • M Inamori,
    • N Nakajima,
    • M Watanabe,
    • N Kubota,
    • T Yamauchi,
    • T Kadowaki,
    • K Wada,
    • H Nakagama,
    • and A Nakajima
    2008 57:1531-1538

  • Adiponectin plays a protective role in caerulein-induced acute pancreatitis in mice fed a high-fat diet

    • H Araki,
    • T Nishihara,
    • M Matsuda,
    • A Fukuhara,
    • S Kihara,
    • T Funahashi,
    • T R Kataoka,
    • Y Kamada,
    • T Kiyohara,
    • S Tamura,
    • N Hayashi,
    • and I Shimomura
    2008 57:1431-1440

  • Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer

    • G Feldmann,
    • N Habbe,
    • S Dhara,
    • S Bisht,
    • H Alvarez,
    • V Fendrich,
    • R Beaty,
    • M Mullendore,
    • C Karikari,
    • N Bardeesy,
    • M M Ouellette,
    • W Yu,
    • and A Maitra
    2008 57:1420-1430

  • Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis

    • C L Noble,
    • A R Abbas,
    • J Cornelius,
    • C W Lees,
    • G-T Ho,
    • K Toy,
    • Z Modrusan,
    • N Pal,
    • F Zhong,
    • S Chalasani,
    • H Clark,
    • I D Arnott,
    • I D Penman,
    • J Satsangi,
    • and L Diehl
    2008 57:1398-1405

  • Psychological stress and coping in IBD

    • James Goodhand,
    • and David Rampton
    2008 57:1345-1347

  • An evidence-based alcohol policy

    • Nick Sheron,
    • Noel Olsen,
    • and Ian Gilmore
    2008 57:1341-1344

  • Dissection of familial correlations in hepatitis C virus (HCV) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection

    • S Plancoulaine,
    • M K Mohamed,
    • N Arafa,
    • I Bakr,
    • C Rekacewicz,
    • D-A Trégouët,
    • D Obach,
    • M El Daly,
    • V Thiers,
    • C Féray,
    • M Abdel-Hamid,
    • L Abel,
    • and A Fontanet
    2008 57:1268-1274

  • Inherited predisposition to colorectal adenomas caused by multiple rare alleles of MUTYH but not OGG1, NUDT1, NTH1 or NEIL 1, 2 or 3

    • A R Dallosso,
    • S Dolwani,
    • N Jones,
    • S Jones,
    • J Colley,
    • J Maynard,
    • S Idziaszczyk,
    • V Humphreys,
    • J Arnold,
    • A Donaldson,
    • D Eccles,
    • A Ellis,
    • D G Evans,
    • I M Frayling,
    • F J Hes,
    • R S Houlston,
    • E R Maher,
    • M Nielsen,
    • S Parry,
    • E Tyler,
    • V Moskvina,
    • J P Cheadle,
    • and J R Sampson
    2008 57:1252-1255

  • Effects of bile acids on pancreatic ductal bicarbonate secretion in guinea pig

    • V Venglovecz,
    • Z Rakonczay Jr,
    • B Ózsvári,
    • T Takács,
    • J Lonovics,
    • A Varró,
    • M A Gray,
    • B E Argent,
    • and P Hegyi
    2008 57:1102-1112

  • Common variants in mismatch repair genes and risk of colorectal cancer

    • T Koessler,
    • M Z Oestergaard,
    • H Song,
    • J Tyrer,
    • B Perkins,
    • A M Dunning,
    • D F Easton,
    • and P D P Pharoah
    2008 57:1097-1101

  • Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett’s oesophagus

    • G H Koek,
    • D Sifrim,
    • T Lerut,
    • J Janssens,
    • and J Tack
    2008 57:1056-1064

  • Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett’s oesophagus

    • S J Leedham,
    • S L Preston,
    • S A C McDonald,
    • G Elia,
    • P Bhandari,
    • D Poller,
    • R Harrison,
    • M R Novelli,
    • J A Jankowski,
    • and N A Wright
    2008 57:1041-1048

  • The European consensus on ulcerative colitis: new horizons?

    • Eduard F Stange,
    • and Simon P L Travis
    2008 57:1029-1031

  • A problem-oriented approach to liver disease in oncology patients

    • G B McDonald,
    • and D Frieze
    2008 57:987-1003

  • Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo

    • C Brockschmidt,
    • H Hirner,
    • N Huber,
    • T Eismann,
    • A Hillenbrand,
    • G Giamas,
    • B Radunsky,
    • O Ammerpohl,
    • B Bohm,
    • D Henne-Bruns,
    • H Kalthoff,
    • F Leithäuser,
    • A Trauzold,
    • and U Knippschild
    2008 57:799-806

  • High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas

    • S Le Gouvello,
    • S Bastuji-Garin,
    • N Aloulou,
    • H Mansour,
    • M-T Chaumette,
    • F Berrehar,
    • A Seikour,
    • A Charachon,
    • M Karoui,
    • K Leroy,
    • J-P Farcet,
    • and I Sobhani
    2008 57:772-779

  • Mechanisms of epithelial translocation of the {alpha}2-gliadin-33mer in coeliac sprue

    • M Schumann,
    • J F Richter,
    • I Wedell,
    • V Moos,
    • M Zimmermann-Kordmann,
    • T Schneider,
    • S Daum,
    • M Zeitz,
    • M Fromm,
    • and J D Schulzke
    2008 57:747-754

  • An unusual cause of abdominal fullness in a patient with Raynaud’s phenomenon

    • A Hokama,
    • K Kishimoto,
    • M Nakamoto,
    • N Kinjo,
    • F Kinjo,
    • and J Fujita
    2008 57:733

  • NOTICE 2008 57:560

  • Adalimumab-induced lupus erythematosus in Crohn’s disease patients previously treated with infliximab

    • Míriam Mañosa,
    • Eugeni Domènech,
    • Laura Marín,
    • Alejandro Olivé,
    • Yamile Zabana,
    • Eduard Cabré,
    • and Miquel A Gassull
    2008 57:559

  • Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study

    • M R Kraus,
    • A Schäfer,
    • K Schöttker,
    • C Keicher,
    • B Weissbrich,
    • I Hofbauer,
    • and M Scheurlen
    2008 57:531-536

  • Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C

    • M Persico,
    • M Capasso,
    • R Russo,
    • E Persico,
    • L Crocè,
    • C Tiribelli,
    • and A Iolascon
    2008 57:507-515

  • Preconditioning with death ligands FasL and TNF-{alpha} protects the cirrhotic mouse liver against ischaemic injury

    • J-H Jang,
    • W Moritz,
    • R Graf,
    • and P-A Clavien
    2008 57:492-499

  • Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitisAn unusual case of ascites

    • M C Wapenaar,
    • A J Monsuur,
    • A A van Bodegraven,
    • R K Weersma,
    • M R Bevova,
    • R K Linskens,
    • P Howdle,
    • G Holmes,
    • C J Mulder,
    • G Dijkstra,
    • D A van Heel,
    • and C Wijmenga
    2008 57:463-467

  • Long-term outcome, growth and digestive function in children 2 to 18 years after intestinal transplantation

    • F Lacaille,
    • N Vass,
    • F Sauvat,
    • D Canioni,
    • V Colomb,
    • C Talbotec,
    • N Patey-Mariaud De Serre,
    • J Salomon,
    • J-P Hugot,
    • J-P Cézard,
    • Y Révillon,
    • F M Ruemme,
    • and O Goulet
    2008 57:455-461

  • Leptin and the risk of Barrett’s oesophagus

    • B J Kendall,
    • G A Macdonald,
    • N K Hayward,
    • J B Prins,
    • I Brown,
    • N Walker,
    • N Pandeya,
    • A C Green,
    • P M Webb,
    • D C Whiteman,
    • and for the Study of Digestive Health
    2008 57:448-454

  • Brain-derived neurotrophic factor amplifies neurotransmitter responses and promotes synaptic communication in the enteric nervous system

    • W Boesmans,
    • P Gomes,
    • J Janssens,
    • J Tack,
    • and P Vanden Berghe
    2008 57:314-322

  • Confocal chromoscopic endomicroscopy is superior to chromoscopy alone for the detection and characterisation of intraepithelial neoplasia in chronic ulcerative colitis

    • D P Hurlstone,
    • R Kiesslich,
    • M Thomson,
    • R Atkinson,
    • and S S Cross
    2008 57:196-204

  • Detrimental role for CD4+ T lymphocytes in murine diffuse peritonitis due to inhibition of local bacterial elimination

    • M Busse,
    • T Traeger,
    • C Pötschke,
    • A Billing,
    • A Dummer,
    • E Friebe,
    • C Kiank,
    • U Grunwald,
    • R S Jack,
    • C Schütt,
    • C-D Heidecke,
    • S Maier,
    • and B M Bröker
    2008 57:188-195

  • Guidelines on the irritable bowel syndrome: mechanisms and practical management

    • R Spiller,
    • Q Aziz,
    • F Creed,
    • A Emmanuel,
    • L Houghton,
    • P Hungin,
    • R Jones,
    • D Kumar,
    • G Rubin,
    • N Trudgill,
    • and P Whorwell
    2007 56:1770-1798

  • Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome

    • T Kaiser,
    • J Langhorst,
    • H Wittkowski,
    • K Becker,
    • A W Friedrich,
    • A Rueffer,
    • G J Dobos,
    • J Roth,
    • and D Foell
    2007 56:1706-1713

  • The association between gastro-oesophageal reflux disease and asthma: a systematic review

    • B D Havemann,
    • C A Henderson,
    • and H B El-Serag
    2007 56:1654-1664

  • Is the downregulation of EphB2 receptor expression during colorectal tumorigenesis due to hypoxia?

    • Abderrahmane Kaidi,
    • Morganaden Moorghen,
    • Ann Caroline Williams,
    • and Christos Paraskeva
    2007 56:1637-1638

  • Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation

    • Alexandra Daley,
    • Roger Randall,
    • Michael Darsley,
    • Naheed Choudhry,
    • Nicola Thomas,
    • Ian R Sanderson,
    • Nick M Croft,
    • and Paul Kelly
    2007 56:1550-1556

  • Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease

    • Liesbet Henckaerts,
    • Marie Pierik,
    • Marie Joossens,
    • Marc Ferrante,
    • Paul Rutgeerts,
    • and Séverine Vermeire
    2007 56:1536-1542

  • COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett’s oesophagus and oesophageal adenocarcinoma

    • Shumei Song,
    • Sushovan Guha,
    • Kaifeng Liu,
    • Navtej S Buttar,
    • and Robert S Bresalier
    2007 56:1512-1521

  • Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis

    • Ajith K Siriwardena,
    • James M Mason,
    • Srinivasan Balachandra,
    • Anil Bagul,
    • Simon Galloway,
    • Laura Formela,
    • Jonathan G Hardman,
    • and Saurabh Jamdar
    2007 56:1439-1444

  • Deficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+ mice

    • Owen J Sansom,
    • Fiona C Mansergh,
    • Martin J Evans,
    • Julie A Wilkins,
    • and Alan R Clarke
    2007 56:1410-1414

  • Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation

    • Shotaro Nakamura,
    • Hongtao Ye,
    • Chris M Bacon,
    • Alison Goatly,
    • Hongxiang Liu,
    • Alison H Banham,
    • Roland Ventura,
    • Takayuki Matsumoto,
    • Mitsuo Iida,
    • Yutaka Ohji,
    • Takashi Yao,
    • Masazumi Tsuneyoshi,
    • and Ming-Qing Du
    2007 56:1358-1363

  • Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD)

    • M Yoneda,
    • K Fujita,
    • M Inamori,
    • A Nakajima,
    • M Tamano,
    • and H Hiraishi
    2007 56:1330-1331

  • Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells

    • Mariano Hurtado,
    • Juan José Lozano,
    • Elisabeth Castellanos,
    • Luis A López-Fernández,
    • Keith Harshman,
    • Carlos Martínez-A,
    • Angel R Ortiz,
    • Timothy M Thomson,
    • and Rosanna Paciucci
    2007 56:1266-1274

  • Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial

    • W J Sandborn,
    • S B Hanauer,
    • P Rutgeerts,
    • R N Fedorak,
    • M Lukas,
    • D G MacIntosh,
    • R Panaccione,
    • D Wolf,
    • J D Kent,
    • B Bittle,
    • J Li,
    • and P F Pollack
    2007 56:1232-1239

  • Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn’s disease

    • Severine Vermeire,
    • Maja Noman,
    • Gert Van Assche,
    • Filip Baert,
    • Geert D’Haens,
    • and Paul Rutgeerts
    2007 56:1226-1231

  • The classics in perspective

    • Julián Panés,
    • and Subrata Ghosh
    2007 56:1184-1186

  • Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk?

    • Stephen B Hanauer
    2007 56:1181-1183

  • Are we meeting the standards set for endoscopy? Results of a large-scale prospective survey of endoscopic retrograde cholangio-pancreatograph practice

    • Earl J Williams,
    • Steve Taylor,
    • Peter Fairclough,
    • Adrian Hamlyn,
    • Richard F Logan,
    • Derrick Martin,
    • Stuart A Riley,
    • Peter Veitch,
    • Mark Wilkinson,
    • Paula J Williamson,
    • Martin Lombard,
    • and on behalf of participating units, BSG Audit of ERCP
    2007 56:821-829

  • Predicting response to peginterferon {alpha}-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B

    • F Bonino,
    • P Marcellin,
    • G K K Lau,
    • S Hadziyannis,
    • R Jin,
    • T Piratvisuth,
    • G Germanidis,
    • C Yurdaydin,
    • M Diago,
    • S Gurel,
    • M-Y Lai,
    • M R Brunetto,
    • P Farci,
    • M Popescu,
    • P McCloud,
    • and for the Peginterferon Alfa-2a HBeAg-Negative Chronic Hepatitis B Study Group
    2007 56:699-705

  • Option appraisal of population-based colorectal cancer screening programmes in England

    • Paul Tappenden,
    • James Chilcott,
    • Simon Eggington,
    • Hannah Sakai,
    • Jonathon Karnon,
    • and Julietta Patnick
    2007 56:677-684

  • Acute surgical abdomen—an atypical presentation of Plasmodium vivax malaria

    • Sunil Gopisetty,
    • Jonahan Sarveswaran,
    • Raj Achuthan,
    • J Davies,
    • and J R Ausobsky
    2007 56:447-448

  • Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonise hepatic fibrosis

    • Kohji Kinoshita,
    • Yuji Iimuro,
    • Jiro Fujimoto,
    • Yutaka Inagaki,
    • Kazuhiko Namikawa,
    • Hiroshi Kiyama,
    • Yuji Nakajima,
    • Kohji Otogawa,
    • Norifumi Kawada,
    • Scott L Friedman,
    • and Kazuo Ikeda
    2007 56:396-404

  • Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study

    • Alexander C Ford,
    • David Forman,
    • Alastair G Bailey,
    • Anthony T R Axon,
    • and Paul Moayyedi
    2007 56:321-327

  • Genetic polymorphisms of mannan binding lectin (MBL), serum levels of MBL, the MBL associated serine protease and H-ficolin in patients with Crohn’s disease

    • R G Nielsen,
    • I Vind,
    • P Munkholm,
    • J C Jensenius,
    • S Thiel,
    • and S Husby
    2007 56:311-312

  • Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene

    • H E Wasmuth,
    • A Glantz,
    • H Keppeler,
    • E Simon,
    • C Bartz,
    • W Rath,
    • L-Å Mattsson,
    • H-U Marschall,
    • and F Lammert
    2007 56:265-270

  • Prion infectivity in variant Creutzfeldt–Jakob disease rectum

    • J D F Wadsworth,
    • S Joiner,
    • K Fox,
    • J M Linehan,
    • M Desbruslais,
    • S Brandner,
    • E A Asante,
    • and J Collinge
    2007 56:90-94

  • Inflammatory bowel disease: is it really just another break in the wall?

    • C R Weber,
    • and J R Turner
    2007 56:6-8

  • ECCO Consensus on the Management of Crohn's Disease 2006 55:i1-i58

  • Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer

    • R C Niessen,
    • M J W Berends,
    • Y Wu,
    • R H Sijmons,
    • H Hollema,
    • M J L Ligtenberg,
    • H E K de Walle,
    • E G E de Vries,
    • A Karrenbeld,
    • C H C M Buys,
    • A G J van der Zee,
    • R M W Hofstra,
    • and J H Kleibeuker
    2006 55:1781-1788

  • Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations

    • A Lanas,
    • L A García-Rodríguez,
    • M T Arroyo,
    • F Gomollón,
    • F Feu,
    • A González-Pérez,
    • E Zapata,
    • G Bástida,
    • L Rodrigo,
    • S Santolaria,
    • M Güell,
    • C M de Argila,
    • E Quintero,
    • F Borda,
    • J M Piqué,
    • and on behalf of the Investigators of the Asociación Española de Gastroenterología (AEG)
    2006 55:1731-1738

  • Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vivo

    • M B Resnick,
    • E Sabo,
    • P A Meitner,
    • S S Kim,
    • Y Cho,
    • H K Kim,
    • R Tavares,
    • and S F Moss
    2006 55:1717-1724

  • Treatment of oesophageal ulcerations using endoscopic transplantation of tissue-engineered autologous oral mucosal epithelial cell sheets in a canine model

    • T Ohki,
    • M Yamato,
    • D Murakami,
    • R Takagi,
    • J Yang,
    • H Namiki,
    • T Okano,
    • and K Takasaki
    2006 55:1704-1710

  • Genes and environment in irritable bowel syndrome: one step forward

    • N J Talley
    2006 55:1694-1696

  • Does delayed gastric emptying really cause symptoms in functional dyspepsia? We still doubt it! • Author’s reply

    • N J Talley,
    • G R Locke III,
    • J Tack,
    • and M Camilleri
    2006 55:1674

  • Balloon gastrostomy migration leading to acute pancreatitis

    • J Periselneris,
    • R England,
    • and M Hull
    2006 55:1673-1674

  • Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis

    • S Joossens,
    • J-F Colombel,
    • C Landers,
    • D Poulain,
    • K Geboes,
    • X Bossuyt,
    • S Targan,
    • P Rutgeerts,
    • and W Reinisch
    2006 55:1667-1669

  • Anti-TNF-{alpha} for treatment of amyloidosis associated with Crohn’s disease • Author’s reply

    • A Fernández-Nebro,
    • I Ureña,
    • M V Irigoyen,
    • R García-Vicuña,
    • S Konno,
    • M Iizuka,
    • Y Horie,
    • H Itou,
    • K Shindo,
    • and S Watanabe
    2006 55:1666-1667

  • A pilot study in patients with established advanced liver fibrosis using pirfenidone

    • J Armendáriz-Borunda,
    • M C Islas-Carbajal,
    • E Meza-García,
    • A R Rincón,
    • S Lucano,
    • A S Sandoval,
    • A Salazar,
    • J Berumen,
    • A Alvarez,
    • A Covarrubias,
    • G Aréchiga,
    • and L García
    2006 55:1663-1665

  • Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease

    • I N Guha,
    • J Parkes,
    • P R Roderick,
    • S Harris,
    • and W M Rosenberg
    2006 55:1650-1660

  • Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy

    • M Sherman,
    • E M Yoshida,
    • M Deschenes,
    • M Krajden,
    • V G Bain,
    • K Peltekian,
    • F Anderson,
    • K Kaita,
    • S Simonyi,
    • R Balshaw,
    • S S Lee,
    • and the Canadian Pegasys Study Group
    2006 55:1631-1638

  • Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment

    • K Weissenborn,
    • J C Ennen,
    • M Bokemeyer,
    • B Ahl,
    • U Wurster,
    • H Tillmann,
    • C Trebst,
    • H Hecker,
    • and G Berding
    2006 55:1624-1630

  • Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours

    • G B Turner,
    • B T Johnston,
    • D R McCance,
    • A McGinty,
    • R G P Watson,
    • C C Patterson,
    • and J E S Ardill
    2006 55:1586-1591

  • Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial

    • G Van Assche,
    • W J Sandborn,
    • B G Feagan,
    • B A Salzberg,
    • D Silvers,
    • P S Monroe,
    • W M Pandak,
    • F H Anderson,
    • J F Valentine,
    • G E Wild,
    • D J Geenen,
    • R Sprague,
    • S R Targan,
    • P Rutgeerts,
    • V Vexler,
    • D Young,
    • and R S Shames
    2006 55:1568-1574

  • Alterations in intestinal permeability

    • M C Arrieta,
    • L Bistritz,
    • and J B Meddings
    2006 55:1512-1520

  • Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil

    • J E Yeon,
    • W Yoo,
    • S P Hong,
    • Y J Chang,
    • S K Yu,
    • J H Kim,
    • Y S Seo,
    • H J Chung,
    • M S Moon,
    • S-O Kim,
    • K S Byun,
    • and C H Lee
    2006 55:1488-1495

  • Disease severity and genetic pathways in attenuated familial adenomatous polyposis vary greatly but depend on the site of the germline mutation

    • O M Sieber,
    • S Segditsas,
    • A L Knudsen,
    • J Zhang,
    • J Luz,
    • A J Rowan,
    • S L Spain,
    • C Thirlwell,
    • K M Howarth,
    • E E M Jaeger,
    • J Robinson,
    • E Volikos,
    • A Silver,
    • G Kelly,
    • S Aretz,
    • I Frayling,
    • P Hutter,
    • M Dunlop,
    • T Guenther,
    • K Neale,
    • R Phillips,
    • K Heinimann,
    • and I P M Tomlinson
    2006 55:1440-1448

  • Treating viral hepatitis C: efficacy, side effects, and complications

    • M P Manns,
    • H Wedemeyer,
    • and M Cornberg
    2006 55:1350-1359

  • Reduced microbial diversity in inflammatory bowel diseases

    • S J Ott,
    • and S Schreiber
    2006 55:1207

  • Fertility and pregnancy in the patient with inflammatory bowel disease

    • U Mahadevan
    2006 55:1198-1206

  • A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon {gamma} antibody, in patients with moderate to severe Crohn’s disease

    • W Reinisch,
    • D W Hommes,
    • G Van Assche,
    • J-F Colombel,
    • J-P Gendre,
    • B Oldenburg,
    • A Teml,
    • K Geboes,
    • H Ding,
    • L Zhang,
    • M Tang,
    • M Cheng,
    • S J H van Deventer,
    • P Rutgeerts,
    • and T Pearce
    2006 55:1138-1144

  • Fontolizumab, a humanised anti-interferon {gamma} antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn’s disease

    • D W Hommes,
    • T L Mikhajlova,
    • S Stoinov,
    • D Stimac,
    • B Vucelic,
    • J Lonovics,
    • M Zákuciová,
    • G D’Haens,
    • G Van Assche,
    • S Ba,
    • S Lee,
    • and T Pearce
    2006 55:1131-1137

  • Molecular characterisation of non-absorptive and absorptive enterocytes in human small intestine

    • N Gassler,
    • D Newrzella,
    • C Böhm,
    • S Lyer,
    • L Li,
    • O Sorgenfrei,
    • L van Laer,
    • B Sido,
    • J Mollenhauer,
    • A Poustka,
    • P Schirmacher,
    • and N Gretz
    2006 55:1084-1089

  • Acute hepatitis C virus infection: a neglected disease?

    • W L Irving
    2006 55:1075-1077

  • How do SSRIs help patients with irritable bowel syndrome?

    • F Creed
    2006 55:1065-1067

  • Small bowel transplantation in the UK

    • S J Middleton,
    • and N V Jamieson
    2006 55:1047

  • Recent advances in coeliac disease

    • D A van Heel,
    • and J West
    2006 55:1037-1046

  • CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies

    • S Ogino,
    • M Cantor,
    • T Kawasaki,
    • M Brahmandam,
    • G J Kirkner,
    • D J Weisenberger,
    • M Campan,
    • P W Laird,
    • M Loda,
    • and C S Fuchs
    2006 55:1000-1006

  • Cancer risks in LKB1 germline mutation carriers

    • H Mehenni,
    • N Resta,
    • J-G Park,
    • M Miyaki,
    • G Guanti,
    • and M C Costanza
    2006 55:984-990

  • Functional dyspepsia, delayed gastric emptying, and impaired quality of life

    • N J Talley,
    • G R Locke III,
    • B D Lahr,
    • A R Zinsmeister,
    • G Tougas,
    • G Ligozio,
    • M A Rojavin,
    • and J Tack
    2006 55:933-939

  • Does delayed gastric emptying really cause symptoms in functional dyspepsia?

    • M Camilleri
    2006 55:909-910

  • A novel integrin {alpha}5ß1 binding domain in module 4 of connective tissue growth factor (CCN2/CTGF) promotes adhesion and migration of activated pancreatic stellate cells

    • R Gao,
    • and D R Brigstock
    2006 55:856-862

  • Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial

    • P Marteau,
    • M Lémann,
    • P Seksik,
    • D Laharie,
    • J F Colombel,
    • Y Bouhnik,
    • G Cadiot,
    • J C Soulé,
    • A Bourreille,
    • E Metman,
    • E Lerebours,
    • F Carbonnel,
    • J L Dupas,
    • M Veyrac,
    • B Coffin,
    • J Moreau,
    • V Abitbol,
    • S Blum-Sperisen,
    • and J Y Mary
    2006 55:842-847

  • Evidence for association of OCTN genes and IBD5 with ulcerative colitis

    • S Waller,
    • M Tremelling,
    • F Bredin,
    • L Godfrey,
    • J Howson,
    • and M Parkes
    2006 55:809-814

  • Stratification by sex and subgroup is necessary for RCT on IBS • Authors’ reply

    • Z X Bian,
    • A Schneider,
    • P Enck,
    • and K Streitberger
    2006 55:743-744

  • A 93 year old man with the PRSS1 R122H mutation, low SPINK1 expression, and no pancreatitis: insights into phenotypic non-penetrance

    • A Khalid,
    • S Finkelstein,
    • B Thompson,
    • L Kelly,
    • C Hanck,
    • T E Godfrey,
    • and D C Whitcomb
    2006 55:728-731

  • Acupuncture treatment in irritable bowel syndrome

    • A Schneider,
    • P Enck,
    • K Streitberger,
    • C Weiland,
    • S Bagheri,
    • S Witte,
    • H-C Friederich,
    • W Herzog,
    • and S Zipfel
    2006 55:649-654

  • Independent component analysis of the EEG: is this the way forward for understanding abnormalities of brain-gut signalling?

    • A R Hobson,
    • and A Hillebrand
    2006 55:597-600

  • EDITOR’S QUIZ: GI SNAPSHOT 2006 55:546

  • Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease

    • R P Anderson,
    • D A van Heel,
    • J A Tye-Din,
    • D P Jewell,
    • and A V S Hill
    2006 55:485-491

  • Crohn’s disease: why the disparity in mortality?

    • E V Loftus Jr
    2006 55:447-449

  • New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett’s oesophagus

    • R J Playford
    2006 55:442

  • Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?

    • B E Sands
    2006 55:437-441

  • Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes

    • J Macías,
    • J A Girón-González,
    • M González-Serrano,
    • D Merino,
    • P Cano,
    • J A Mira,
    • A Arizcorreta-Yarza,
    • J Ruíz-Morales,
    • J M Lomas-Cabeza,
    • J A García-García,
    • J E Corzo,
    • and J A Pineda
    2006 55:409-414

  • Treatment of active Crohn’s disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial

    • T Johnson,
    • S Macdonald,
    • S M Hill,
    • A Thomas,
    • and M S Murphy
    2006 55:356-361

  • Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease

    • J O Lindsay,
    • K Whelan,
    • A J Stagg,
    • P Gobin,
    • H O Al-Hassi,
    • N Rayment,
    • M A Kamm,
    • S C Knight,
    • and A Forbes
    2006 55:348-355

  • Influence of ghrelin on interdigestive gastrointestinal motility in humans

    • J Tack,
    • I Depoortere,
    • R Bisschops,
    • C Delporte,
    • B Coulie,
    • A Meulemans,
    • J Janssens,
    • and T Peeters
    2006 55:327-333

  • Novel mechanism for impaired nitrergic relaxation in achalasia

    • G E Boeckxstaens
    2006 55:304-305

  • Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas

    • K Völp,
    • M-L Brezniceanu,
    • S Bösser,
    • T Brabletz,
    • T Kirchner,
    • D Göttel,
    • S Joos,
    • and M Zörnig
    2006 55:234-242

  • An unusual cause of pancreatitis

    • T-C Lee,
    • K-L Liu,
    • J-T Lin,
    • Y-W Tien,
    • T-L Mao,
    • and H-P Wang
    2006 55:164

  • Is thiopurine therapy in ulcerative colitis as effective as in Crohn’s disease?

    • S Ghosh,
    • R Chaudhary,
    • M Carpani,
    • and R J Playford
    2006 55:6-8

  • Abstracts 2005 54:a1-a117

  • How can a migraine cause faecal incontinence?

    • K Honein,
    • J Boujaoude,
    • M Chemaly,
    • C Yaghi,
    • R Karam,
    • and R Sayegh
    2005 54:1817

  • Diagnosis of small bowel Crohn’s disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis

    • J G Albert,
    • F Martiny,
    • A Krummenerl,
    • K Stock,
    • J Leßke,
    • C M Göbel,
    • E Lotterer,
    • H H Nietsch,
    • C Behrmann,
    • and W E Fleig
    2005 54:1721-1727

  • 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study

    • T P van Staa,
    • T Card,
    • R F Logan,
    • and H G M Leufkens
    2005 54:1573-1578

  • NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn’s disease

    • T Watanabe,
    • A Kitani,
    • and W Strober
    2005 54:1515-1518

  • COX-2 chronology

    • C J Hawkey
    2005 54:1509-1514

  • High levels of disease related prion protein in the ileum in variant Creutzfeldt-Jakob disease

    • S Joiner,
    • J M Linehan,
    • S Brandner,
    • J D F Wadsworth,
    • and J Collinge
    2005 54:1506-1508

  • Sex specific alterations in autonomic function among patients with irritable bowel syndrome

    • K Tillisch,
    • E A Mayer,
    • J S Labus,
    • J Stains,
    • L Chang,
    • and B D Naliboff
    2005 54:1396-1401

  • Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study

    • P Aro,
    • J Ronkainen,
    • N J Talley,
    • T Storskrubb,
    • E Bolling-Sternevald,
    • and L Agréus
    2005 54:1377-1383

  • Preventing TB in patients with Crohn’s disease needing infliximab or other anti-TNF therapy

    • D S Rampton
    2005 54:1360-1362

  • Inflammatory biomarkers predict relapse in IBD

    • P Hanaway,
    • and A Roseth
    2005 54:1346-1347

  • Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients

    • P B Jeppesen,
    • E L Sanguinetti,
    • A Buchman,
    • L Howard,
    • J S Scolapio,
    • T R Ziegler,
    • J Gregory,
    • K A Tappenden,
    • J Holst,
    • and P B Mortensen
    2005 54:1224-1231

  • T cells in peripheral blood after gluten challenge in coeliac disease

    • R P Anderson,
    • D A van Heel,
    • J A Tye-Din,
    • M Barnardo,
    • M Salio,
    • D P Jewell,
    • and A V S Hill
    2005 54:1217-1223

  • Food elimination in IBS: the case for IgG testing remains doubtful • Author’s reply

    • J O Hunter,
    • P J Whorwell,
    • W Atkinson,
    • and T A Sheldon
    2005 54:1203

  • CHEMORADIOTHERAPY FOR COLORECTAL CANCER

    • N Andre,
    • and W Schmiegel
    2005 54:1194-1202

  • Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas

    • Y Murakami,
    • K Saigo,
    • H Takashima,
    • M Minami,
    • T Okanoue,
    • C Bréchot,
    • and P Paterlini-Bréchot
    2005 54:1162-1168

  • Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

    • A Kandiel,
    • A G Fraser,
    • B I Korelitz,
    • C Brensinger,
    • and J D Lewis
    2005 54:1121-1125

  • Ghrelin treatment reverses the reduction in weight gain and body fat in gastrectomised mice

    • C Dornonville de la Cour,
    • A Lindqvist,
    • E Egecioglu,
    • Y C L Tung,
    • V Surve,
    • C Ohlsson,
    • J-O Jansson,
    • C Erlanson-Albertsson,
    • S L Dickson,
    • and R Håkanson
    2005 54:907-913

  • Adalimumab use in pregnancy

    • L Vesga,
    • J P Terdiman,
    • and U Mahadevan
    2005 54:890

  • ENDOSCOPIC THERAPY FOR BARRETT’S OESOPHAGUS

    • H Barr,
    • N Stone,
    • and B Rembacken
    2005 54:875-884

  • Reparative properties of a commercial fish protein hydrolysate preparation

    • A J Fitzgerald,
    • P S Rai,
    • T Marchbank,
    • G W Taylor,
    • S Ghosh,
    • B W Ritz,
    • and R J Playford
    2005 54:775-781

  • Gut mucosal granulocyte activation precedes nitric oxide production: studies in coeliac patients challenged with gluten and corn

    • G Kristjánsson,
    • M Högman,
    • P Venge,
    • and R Hällgren
    2005 54:769-774

  • The time to eradicate gastric cancer is now

    • D Y Graham,
    • and A Shiotani
    2005 54:735-738

  • Epidemiology of gastro-oesophageal reflux disease: a systematic review

    • J Dent,
    • H B El-Serag,
    • M-A Wallander,
    • and S Johansson
    2005 54:710-717

  • Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis

    • E I Rigopoulou,
    • E T Davies,
    • A Pares,
    • K Zachou,
    • C Liaskos,
    • D-P Bogdanos,
    • J Rodes,
    • G N Dalekos,
    • and D Vergani
    2005 54:528-532

  • Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid

    • K Birkenkamp-Demtroder,
    • S H Olesen,
    • F B Sørensen,
    • S Laurberg,
    • P Laiho,
    • L A Aaltonen,
    • and T F Ørntoft
    2005 54:374-384

  • An unusual cause of upper gastrointestinal haemorrhage

    • G D De Palma,
    • M Rega,
    • P Ciamrarra,
    • S Masone,
    • and G Persico
    2005 54:343

  • Wireless capsule endoscopy and Crohn’s disease

    • P Swain
    2005 54:323-326

  • Predicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers?

    • D S Pardi,
    • and W J Sandborn
    2005 54:321-322

  • Microscopic (collagenous and lymphocytic) colitis triggered by food allergy

    • M Weidenhiller,
    • S Müller,
    • D Schwab,
    • E G Hahn,
    • M Raithel,
    • and S Winterkamp
    2005 54:312-313

  • Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery

    • J Cosnes,
    • I Nion-Larmurier,
    • L Beaugerie,
    • P Afchain,
    • E Tiret,
    • and J-P Gendre
    2005 54:237-241

  • Genotypes and phenotypes in Crohn’s disease: do they help in clinical management?

    • C Gasche,
    • and P Grundtner
    2005 54:162-167

  • Prevalence of gastrointestinal diseases in two British national birth cohorts

    • A G C Ehlin,
    • S M Montgomery,
    • A Ekbom,
    • R E Pounder,
    • and A J Wakefield
    2003 52:1117-1121

  • Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients

    • A H Mohsen,
    • P J Easterbrook,
    • C Taylor,
    • B Portmann,
    • R Kulasegaram,
    • S Murad,
    • M Wiselka,
    • and S Norris
    2003 52:1035-1040

  • Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study

    • C J Hawkey,
    • L Laine,
    • T Simon,
    • H Quan,
    • S Shingo,
    • and J Evans
    2003 52:820-826

  • 2002 51:1-900

  • Prospective comparative study of spiral computer tomography and magnetic resonance imaging for detection of hepatocellular carcinoma

    • J Stoker,
    • M G Romijn,
    • R A de Man,
    • J T Brouwer,
    • G J Weverling,
    • J M van Muiswinkel,
    • P E Zondervan,
    • J S Laméris,
    • and J N M Ijzermans
    2002 51:105-107

  • A survey on gastroenterology training in Europe

    • R Bisschops,
    • A Wilmer,
    • and J Tack
    2002 50:724-729

  • Hospital admissions for peptic ulcer and indigestion in London and New York in the 19th and early 20th centuries

    • J H Baron,
    • and A Sonnenberg
    2002 50:568-570

  • Novel cationic trypsinogen (PRSS1) N29T and R122C mutations cause autosomal dominant hereditary pancreatitis

    • R Pfützer,
    • E Myers,
    • S Applebaum-Shapiro,
    • R Finch,
    • I Ellis,
    • J Neoptolemos,
    • J A Kant,
    • and D C Whitcomb
    2002 50:271-272

  • 2002 50:1-138

  • Clinical guidelines on the management of hepatitis C 2001 49:1-21

  • Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression

    • N A Shackel,
    • P H McGuinness,
    • C A Abbott,
    • M D Gorrell,
    • and G W McCaughan
    2001 49:565-576

  • Antagonist: Should we eradicate Helicobacter pylori in non-ulcer dyspepsia?

    • D Pantoflickova,
    • and A L Blum
    2001 48:758-759

  • 2001 48:443-582

  • British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome

    • J Jones,
    • J Boorman,
    • P Cann,
    • A Forbes,
    • J Gomborone,
    • K Heaton,
    • P Hungin,
    • D Kumar,
    • G Libby,
    • R Spiller,
    • N Read,
    • D Silk,
    • and P Whorwell
    2000 47:ii1-ii19

  • Functional genomics in gastroenterology

    • S SCHREIBER,
    • J HAMPE,
    • H EICKHOFF,
    • and H LEHRACH
    2000 47:601-607

  • Postal consent for upper gastrointestinal endoscopy

    • H A Shepherd,
    • D Bowman,
    • B Hancock,
    • J Anglin,
    • and D Hewett
    2000 46:37-39

  • Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status

    • Y Yamaoka,
    • T Kodama,
    • M Kita,
    • J Imanishi,
    • K Kashima,
    • and D Y Graham
    1999 45:804-811

  • Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis

    • G Nardone,
    • S Staibano,
    • A Rocco,
    • E Mezza,
    • F P D'Armiento,
    • L Insabato,
    • A Coppola,
    • G Salvatore,
    • A Lucariello,
    • N Figura,
    • G De Rosa,
    • and G Budillon
    1999 44:789-799

Latest from Gut Education

Latest from Gut Education

Register for free content


Free sample
 This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Gut.
View free sample issue >>

Free archive
The full back archive is now available for Gut. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

  • Email Alert Signup

    • Latest Gastroenterology jobs

    Latest Gastroenterology jobs

    Show me all Gastroenterology
    jobs >>